| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $654,871 | 5 | 71 |
Sells | $9,395,800 | 2 | 29 |
| Schimmelpennink Evert B. | President, CEO and Secretary | 1 | $251,411 | 0 | $0 | $251,411 |
| MCCOLLUM JAMES W | director | 1 | $239,278 | 0 | $0 | $239,278 |
| Chevallard Daniel R. | Chief Financial Officer | 2 | $114,292 | 0 | $0 | $114,292 |
| George Jeffrey P. | director | 1 | $49,890 | 0 | $0 | $49,890 |
| Olsson Shawn | Chief Commercial Officer | 0 | $0 | 1 | $261,022 | $-261,022 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 0 | $0 | 1 | $9.13M | $-9.13M |
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
Over the last 12 months, insiders at LENZ Therapeutics, Inc. have bought $654,871 and sold $9.4M worth of LENZ Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at LENZ Therapeutics, Inc. have bought $8.1M and sold $38M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Schimmelpennink Evert B. (President, CEO and Secretary) — $251,411. MCCOLLUM JAMES W (director) — $239,278. Chevallard Daniel R. (Chief Financial Officer) — $114,292.
The last purchase of 28,089 shares for transaction amount of $251,411 was made by Schimmelpennink Evert B. (President, CEO and Secretary) on 2026‑03‑27.
| 2026-10-29 | Sale | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2.72M 8.3304% | $3.36 | $9.13M | -12.61% | |
| 2026-03-27 | Schimmelpennink Evert B. | President, CEO and Secretary | 28,089 0.0955% | $8.95 | $251,411 | -33.51% | ||
| 2026-03-27 | Chevallard Daniel R. | Chief Financial Officer | 7,500 0.0244% | $8.57 | $64,275 | -33.51% | ||
| 2026-03-27 | George Jeffrey P. | director | 5,592 0.0189% | $8.92 | $49,890 | -33.51% | ||
| 2025-11-17 | Sale | Olsson Shawn | Chief Commercial Officer | 10,000 0.0552% | $26.10 | $261,022 | -68.91% | |
| 2025-11-07 | MCCOLLUM JAMES W | director | 10,500 0.0506% | $22.79 | $239,278 | -63.43% | ||
| 2025-11-07 | Chevallard Daniel R. | Chief Financial Officer | 2,198 0.0106% | $22.76 | $50,017 | -63.43% | ||
| 2025-09-30 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 224,974 2.191% | $46.01 | $10.35M | -78.81% | |
| 2025-09-18 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 135,304 1.2095% | $42.23 | $5.71M | -73.61% | |
| 2025-08-26 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 70,811 0.5847% | $39.01 | $2.76M | -66.82% | |
| 2025-08-25 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 78,237 0.6548% | $39.54 | $3.09M | -67.54% | |
| 2025-08-22 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 39,046 0.3318% | $40.15 | $1.57M | -67.59% | |
| 2025-08-18 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 45,713 0.3731% | $38.56 | $1.76M | -65.90% | |
| 2025-08-15 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 215,000 1.7975% | $39.50 | $8.49M | -64.33% | |
| 2025-07-10 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 191,376 1.3772% | $34.00 | $6.51M | -50.70% | |
| 2025-06-27 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 200,000 1.2896% | $30.46 | $6.09M | -39.65% | |
| 2025-06-20 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 234,801 1.5054% | $30.29 | $7.11M | -35.09% | |
| 2025-06-18 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 100,000 0.6339% | $29.95 | $3M | -35.13% | |
| 2025-06-10 | Sale | Versant Venture Capital VI, L.P. | 10 percent owner | 350,000 2.1483% | $29.00 | $10.15M | -18.20% | |
| 2024-05-14 | Chevallard Daniel R. | Chief Financial Officer | 3,188 0.0106% | $15.68 | $49,988 | +53.18% |
| Schimmelpennink Evert B. | President, CEO and Secretary | 77289 0.246% | $270,511.50 | 1 | 0 | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 57559 0.1832% | $201,456.50 | 1 | 1 | +192.09% |
| Chevallard Daniel R. | Chief Financial Officer | 12886 0.041% | $45,101.00 | 3 | 0 | +53.18% |
| MCCOLLUM JAMES W | director | 10500 0.0334% | $36,750.00 | 2 | 0 | +51.19% |
| George Jeffrey P. | director | 5592 0.0178% | $19,572.00 | 1 | 0 |
$5,552,811 | 165 | 5.84% | $106.2M | |
$16,280,851 | 76 | 1.48% | $118.27M | |
$4,898,715 | 46 | 40.75% | $114.69M | |
$130,095 | 43 | 45.19% | $111.24M | |
$47,438,336 | 33 | -21.38% | $122.37M |
| Increased Positions | 102 | +50.75% | 13M | +45.26% |
| Decreased Positions | 89 | -44.28% | 7M | -24.9% |
| New Positions | 49 | New | 5M | New |
| Sold Out Positions | 56 | Sold Out | 6M | Sold Out |
| Total Postitions | 214 | +6.47% | 35M | +20.36% |